Multi Barrier Reverse Convertible

Symbol: KZIODU
ISIN: CH1390260961
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
28.07.26
07:19:01
- %
- %
EUR
Volume
0
0
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 100.80
Diff. absolute / % 0.30 +0.30%

Determined prices

Last Price 98.95 Volume 68,000
Time 09:22:27 Date 11/05/2026

More Product Information

Core Data

Name Multi Barrier Reverse Convertible
ISIN CH1390260961
Valor 139026096
Symbol KZIODU
Quotation in percent Yes
Coupon p.a. 10.00%
Coupon Premium 7.91%
Coupon Yield 2.09%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
Exercise type American
Currency Euro
First Trading Date 18/12/2024
Date of maturity 18/12/2026
Last trading day 11/12/2026
Settlement Type Cash payout
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Clean
Issuer UBS

Key data

Ask Price (basis for calculation) 101.7000
Maximum yield 2.19%
Maximum yield p.a. 5.54%
Sideways yield 2.19%
Sideways yield p.a. 5.54%

market maker quality Date: 27/07/2026

Average Spread 0.99%
Last Best Bid Price 100.80 %
Last Best Ask Price 101.80 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 100,000
Average Sell Volume 100,000
Average Buy Value 100,521 EUR
Average Sell Value 101,521 EUR
Spreads Availability Ratio 99.91%
Quote Availability 99.91%

Underlyings

Name Sanofi S.A. Merck & Co. Inc. Bayer AG
ISIN FR0000120578 US58933Y1055 DE000BAY0017
Price - 115.57 EUR 44.18 CHF
Date - 28/07/26 09:24 15/07/26 13:08
Cap 91.29 EUR 99.75 USD 19.996 EUR
Distance to Cap -15.26 32.56 27.334
Distance to Cap in % -20.07% 24.61% 57.75%
Is Cap Level reached No No No
Barrier 50.21 EUR 54.86 USD 10.998 EUR
Distance to Barrier 27.58 75.9 36.232
Distance to Barrier in % 35.45% 58.05% 76.71%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.